Intervention Protocol

Augmentation of psychotherapy with d-cycloserine for anxiety disorders

  1. Jonathan C Ipser1,*,
  2. Candice Sander2,
  3. Alon Seifan3,
  4. Dan J Stein4

Editorial Group: Cochrane Depression, Anxiety and Neurosis Group

Published Online: 15 APR 2009

Assessed as up-to-date: 2 FEB 2009

DOI: 10.1002/14651858.CD007803


How to Cite

Ipser JC, Sander C, Seifan A, Stein DJ. Augmentation of psychotherapy with d-cycloserine for anxiety disorders (Protocol). Cochrane Database of Systematic Reviews 2009, Issue 2. Art. No.: CD007803. DOI: 10.1002/14651858.CD007803.

Author Information

  1. 1

    University of Stellenbosch, MRC Research Unit for Anxiety and Stress Disorders, Tygerberg, Western Cape, South Africa

  2. 2

    Die Wilgers, Pretoria, South Africa

  3. 3

    Mount Sinai School of Medicine, New York, USA

  4. 4

    University of Cape Town, Department of Psychiatry and Mental Health, Cape Town, South Africa

*Jonathan C Ipser, MRC Research Unit for Anxiety and Stress Disorders, University of Stellenbosch, PO Box 19063, Tygerberg, Western Cape, 7505, South Africa. jonathan.ipser@uct.ac.za. jonathanipser@gmail.com.

Publication History

  1. Publication Status: New
  2. Published Online: 15 APR 2009

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

1) To provide an estimate of the overall effects of d-cycloserine in improving treatment response and reducing symptom severity in anxiety disorders treated with psychotherapy.

2) To determine whether the efficacy and tolerability of d-cycloserine is specific to particular anxiety disorders.

3) To identify which factors (clinical, methodological) predict response to pharmacotherapy.